Clinical significance of human kallikrein 12 gene expression in gastric cancer

doi:10.3748/wjg.v18.i45.6597

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 45

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4601)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-1) series.

Item

Count

PDF

386

HTML

3719

Figures (1-7)

290

Tables (1-1)

206

Sum=4601

Dec 7, 2012 (publication date) through Dec 19, 2024

Times Cited of This Article

Times Cited (19)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Dec 7, 2012; 18(45): 6597-6604
Published online Dec 7, 2012. doi: 10.3748/wjg.v18.i45.6597

Full Size Figure Download Figure

Figure 3 Overall survival of patients with gastric cancer according to human kallikrein 12 protein expression in the cancer tissues. Patients in the high human kallikrein 12 protein (hK12) expression group had a significantly poorer prognosis than those in the low hK12 expression group. Survival curves are drawn according to the Kaplan-Meier method, using the log-rank test to compare the survival rates (P = 0.002).

Citation: Zhao EH, Shen ZY, Liu H, Jin X, Cao H. Clinical significance of human kallikrein 12 gene expression in gastric cancer. World J Gastroenterol 2012; 18(45): 6597-6604
URL: https://www.wjgnet.com/1007-9327/full/v18/i45/6597.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i45.6597